- DNA polymerase
- Acetylases
- DNA ligases
- Methyltransferase
- RNA ligases
- Reverse Transcriptase
- Others
Epigenetics Market size was valued at US$ 823 Million in 2022 and is projected to reach US$ 2021.73 Million at a CAGR of 13.7% from 2023- 2029. Epigenetics is a study of heritable changes in gene expression which involves the change in phenotype without changing genotype, which in turn affects the reading of genes by cells. Epigenetic changes are natural and regular processes but are also influenced by various factors like lifestyle, environment, age, and state of disease. Epigenetic modifications can manifest a common manner of cells that differentiate terminally to end up as liver cells, skin cells, brain cells, etc. Epigenetic change may have more damaging effects which can lead to diseases like cancer. Systems like histone modification, non-coding RNA-associated gene silencing, and DNA methylation are considered for the initiation of epigenetic change sustainably. In October 2016 Episode an epigenetics data company launched SEED a novel male fertility test to evaluate epigenetic changes on DNA to detect a risk of infertility and poor embryo development.
Study Period
Base Year
CAGR
Largest Market
Fastest Growing Market
The surge in the prevalence of cancer, improving funds and aids for the R&D activities, rise in the partnerships between pharmaceutical and biotechnology companies and research institutes, increase in epigenetics application in non-oncology diseases will propel the epigenetics. Moreover, improved advancements in epigenetics technology, untapped potential of emerging markets like India and China are expected to offer many opportunities for the growth of epigenetics market. However, high instrument cost and the dearth of skilled personnel are expected to hamper the growth of the market.
The epigenetics market key players are: Illumina, Inc. (U.S.), Abcam plc. (U.K), QIAGEN N.V. (Netherland), New England Biolabs, Inc. (U.S.), Merck & Co. (U.S.), Sigma-Aldrich Corporation (U.S.), Genedata AG(Switzerland), Cayman chemical company (U.S), Active Motif (U.S.), Thermo Fisher Scientific, Inc., (U.S.), Diagenode, Inc. (Belgium), Zymo Research Corporation (U.S.)., Episona Inc. (U.S).
The report covers the five regions and 15+ countries market data: North America (United States, Canada), Europe (Germany, France, Italy, Spain, and United Kingdom (UK), Asia Pacific (China, India, Japan, Australia & New Zealand), Latin America (Brazil, Mexico, Argentina) and Middle East and Africa (Saudi Arabia, United Arab Emirates, South Africa).
In our report, we provide 12-15 market players’ information into the report. However, based on the client’s request we will provide additional country and regional market players information as well.
1. Executive Summary |
2. Global Epigenetics Market Introduction |
2.1.Global Epigenetics Market - Taxonomy |
2.2.Global Epigenetics Market - Definitions |
2.2.1.Enzymes |
2.2.2.Instruments |
2.2.3.Application |
2.2.4.Kits and Assays |
2.2.5.Region |
3. Global Epigenetics Market Dynamics |
3.1. Drivers |
3.2. Restraints |
3.3. Opportunities/Unmet Needs of the Market |
3.4. Trends |
3.5. Product Landscape |
3.6. New Product Launches |
3.7. Impact of COVID 19 on Market |
4. Global Epigenetics Market Analysis, 2018-2022 and Forecast 2023-2029 |
4.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) |
4.3. Market Opportunity Analysis |
5. Global Epigenetics Market By Enzymes, 2018-2022 and Forecast 2023-2029 (Sales Value USD Million) |
5.1. DNA polymerase |
5.1.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
5.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.1.3. Market Opportunity Analysis |
5.2. Acetylases |
5.2.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
5.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.2.3. Market Opportunity Analysis |
5.3. DNA ligases |
5.3.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
5.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.3.3. Market Opportunity Analysis |
5.4. Methyltransferase |
5.4.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
5.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.4.3. Market Opportunity Analysis |
5.5. RNA ligases |
5.5.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
5.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.5.3. Market Opportunity Analysis |
5.6. Reverse Transcriptase |
5.6.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
5.6.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.6.3. Market Opportunity Analysis |
5.7. Others |
5.7.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
5.7.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.7.3. Market Opportunity Analysis |
6. Global Epigenetics Market By Instruments, 2018-2022 and Forecast 2023-2029 (Sales Value USD Million) |
6.1. Next generation sequencers |
6.1.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
6.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.1.3. Market Opportunity Analysis |
6.2. Mass spectrometers |
6.2.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
6.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.2.3. Market Opportunity Analysis |
6.3. Sonicators |
6.3.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
6.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.3.3. Market Opportunity Analysis |
6.4. qPCRs |
6.4.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
6.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.4.3. Market Opportunity Analysis |
6.5. Others |
6.5.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
6.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.5.3. Market Opportunity Analysis |
7. Global Epigenetics Market By Application, 2018-2022 and Forecast 2023-2029 (Sales Value USD Million) |
7.1. Oncology |
7.1.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
7.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.1.3. Market Opportunity Analysis |
7.2. Cardiovascular Diseases |
7.2.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
7.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.2.3. Market Opportunity Analysis |
7.3. Metabolic Diseases |
7.3.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
7.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.3.3. Market Opportunity Analysis |
7.4. Inflammatory Diseases |
7.4.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
7.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.4.3. Market Opportunity Analysis |
7.5. Infectious Diseases |
7.5.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
7.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.5.3. Market Opportunity Analysis |
8. Global Epigenetics Market By Kits and Assays, 2018-2022 and Forecast 2023-2029 (Sales Value USD Million) |
8.1. Deep Sequencing Kit |
8.1.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
8.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
8.1.3. Market Opportunity Analysis |
8.2. Bisulfate Conversion Kit |
8.2.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
8.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
8.2.3. Market Opportunity Analysis |
8.3. Methyltransferase Assays |
8.3.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
8.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
8.3.3. Market Opportunity Analysis |
8.4. Chip- Seq Kits |
8.4.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
8.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
8.4.3. Market Opportunity Analysis |
8.5. Immunoprecipitation Kits |
8.5.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
8.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
8.5.3. Market Opportunity Analysis |
8.6. Histone Assay |
8.6.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
8.6.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
8.6.3. Market Opportunity Analysis |
9. Global Epigenetics Market By Region, 2018-2022 and Forecast 2023-2029 (Sales Value USD Million) |
9.1. North America |
9.1.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
9.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
9.1.3. Market Opportunity Analysis |
9.2. Europe |
9.2.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
9.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
9.2.3. Market Opportunity Analysis |
9.3. Asia Pacific (APAC) |
9.3.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
9.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
9.3.3. Market Opportunity Analysis |
9.4. Middle East and Africa (MEA) |
9.4.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
9.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
9.4.3. Market Opportunity Analysis |
9.5. Latin America |
9.5.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
9.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
9.5.3. Market Opportunity Analysis |
10. North America Epigenetics Market ,2018-2022 and Forecast 2023-2029 (Sales Value USD Million) |
10.1. Enzymes Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
10.1.1.DNA polymerase |
10.1.2.Acetylases |
10.1.3.DNA ligases |
10.1.4.Methyltransferase |
10.1.5.RNA ligases |
10.1.6.Reverse Transcriptase |
10.1.7.Others |
10.2. Instruments Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
10.2.1.Next generation sequencers |
10.2.2.Mass spectrometers |
10.2.3.Sonicators |
10.2.4.qPCRs |
10.2.5.Others |
10.3. Application Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
10.3.1.Oncology |
10.3.2.Cardiovascular Diseases |
10.3.3.Metabolic Diseases |
10.3.4.Inflammatory Diseases |
10.3.5.Infectious Diseases |
10.4. Kits and Assays Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
10.4.1.Deep Sequencing Kit |
10.4.2.Bisulfate Conversion Kit |
10.4.3.Methyltransferase Assays |
10.4.4.Chip- Seq Kits |
10.4.5.Immunoprecipitation Kits |
10.4.6.Histone Assay |
10.5. Country Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
10.5.1.United States of America (USA) |
10.5.2.Canada |
11. Europe Epigenetics Market ,2018-2022 and Forecast 2023-2029 (Sales Value USD Million) |
11.1. Enzymes Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
11.1.1.DNA polymerase |
11.1.2.Acetylases |
11.1.3.DNA ligases |
11.1.4.Methyltransferase |
11.1.5.RNA ligases |
11.1.6.Reverse Transcriptase |
11.1.7.Others |
11.2. Instruments Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
11.2.1.Next generation sequencers |
11.2.2.Mass spectrometers |
11.2.3.Sonicators |
11.2.4.qPCRs |
11.2.5.Others |
11.3. Application Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
11.3.1.Oncology |
11.3.2.Cardiovascular Diseases |
11.3.3.Metabolic Diseases |
11.3.4.Inflammatory Diseases |
11.3.5.Infectious Diseases |
11.4. Kits and Assays Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
11.4.1.Deep Sequencing Kit |
11.4.2.Bisulfate Conversion Kit |
11.4.3.Methyltransferase Assays |
11.4.4.Chip- Seq Kits |
11.4.5.Immunoprecipitation Kits |
11.4.6.Histone Assay |
11.5. Country Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
11.5.1.Germany |
11.5.2.France |
11.5.3.Italy |
11.5.4.United Kingdom (UK) |
11.5.5.Spain |
11.5.6.Rest of EU |
12. Asia Pacific (APAC) Epigenetics Market ,2018-2022 and Forecast 2023-2029 (Sales Value USD Million) |
12.1. Enzymes Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
12.1.1.DNA polymerase |
12.1.2.Acetylases |
12.1.3.DNA ligases |
12.1.4.Methyltransferase |
12.1.5.RNA ligases |
12.1.6.Reverse Transcriptase |
12.1.7.Others |
12.2. Instruments Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
12.2.1.Next generation sequencers |
12.2.2.Mass spectrometers |
12.2.3.Sonicators |
12.2.4.qPCRs |
12.2.5.Others |
12.3. Application Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
12.3.1.Oncology |
12.3.2.Cardiovascular Diseases |
12.3.3.Metabolic Diseases |
12.3.4.Inflammatory Diseases |
12.3.5.Infectious Diseases |
12.4. Kits and Assays Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
12.4.1.Deep Sequencing Kit |
12.4.2.Bisulfate Conversion Kit |
12.4.3.Methyltransferase Assays |
12.4.4.Chip- Seq Kits |
12.4.5.Immunoprecipitation Kits |
12.4.6.Histone Assay |
12.5. Country Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
12.5.1.China |
12.5.2.India |
12.5.3.Australia and New Zealand (ANZ) |
12.5.4.Japan |
12.5.5.Rest of APAC |
13. Middle East and Africa (MEA) Epigenetics Market ,2018-2022 and Forecast 2023-2029 (Sales Value USD Million) |
13.1. Enzymes Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
13.1.1.DNA polymerase |
13.1.2.Acetylases |
13.1.3.DNA ligases |
13.1.4.Methyltransferase |
13.1.5.RNA ligases |
13.1.6.Reverse Transcriptase |
13.1.7.Others |
13.2. Instruments Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
13.2.1.Next generation sequencers |
13.2.2.Mass spectrometers |
13.2.3.Sonicators |
13.2.4.qPCRs |
13.2.5.Others |
13.3. Application Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
13.3.1.Oncology |
13.3.2.Cardiovascular Diseases |
13.3.3.Metabolic Diseases |
13.3.4.Inflammatory Diseases |
13.3.5.Infectious Diseases |
13.4. Kits and Assays Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
13.4.1.Deep Sequencing Kit |
13.4.2.Bisulfate Conversion Kit |
13.4.3.Methyltransferase Assays |
13.4.4.Chip- Seq Kits |
13.4.5.Immunoprecipitation Kits |
13.4.6.Histone Assay |
13.5. Country Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
13.5.1.GCC Countries |
13.5.2.South Africa |
13.5.3.Rest of MEA |
14. Latin America Epigenetics Market ,2018-2022 and Forecast 2023-2029 (Sales Value USD Million) |
14.1. Enzymes Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
14.1.1.DNA polymerase |
14.1.2.Acetylases |
14.1.3.DNA ligases |
14.1.4.Methyltransferase |
14.1.5.RNA ligases |
14.1.6.Reverse Transcriptase |
14.1.7.Others |
14.2. Instruments Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
14.2.1.Next generation sequencers |
14.2.2.Mass spectrometers |
14.2.3.Sonicators |
14.2.4.qPCRs |
14.2.5.Others |
14.3. Application Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
14.3.1.Oncology |
14.3.2.Cardiovascular Diseases |
14.3.3.Metabolic Diseases |
14.3.4.Inflammatory Diseases |
14.3.5.Infectious Diseases |
14.4. Kits and Assays Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
14.4.1.Deep Sequencing Kit |
14.4.2.Bisulfate Conversion Kit |
14.4.3.Methyltransferase Assays |
14.4.4.Chip- Seq Kits |
14.4.5.Immunoprecipitation Kits |
14.4.6.Histone Assay |
14.5. Country Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
14.5.1.Brazil |
14.5.2.Mexico |
14.5.3.Rest of LA |
15. Competition Landscape |
15.1. Market Player Profiles (Introduction, Brand/Product Sales, Financial Analysis, Product Offerings, Key Developments, Collaborations, M & A, Strategies, and SWOT Analysis) |
15.2.1.Illumina, Inc. (U.S.) |
15.2.2.Abcam plc. (U.K) |
15.2.3.QIAGEN N.V. (Netherland) |
15.2.4.New England Biolabs, Inc. (U.S.) |
15.2.5.Merck & Co. (U.S.) |
15.2.6.Sigma-Aldrich Corporation (U.S.) |
15.2.7.Genedata AG(Switzerland) |
15.2.8.Cayman chemical company (U.S) |
15.2.9.Active Motif (U.S.) |
15.2.10.Thermo Fisher Scientific, Inc., (U.S.) |
15.2.11.Diagenode, Inc. (Belgium) |
15.2.12.Zymo Research Corporation (U.S.). |
15.2.13.Episona Inc. (U.S). |
16. Research Methodology |
17. Appendix and Abbreviations |